Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]MNI-958 PET in AD, PSP, and Healthy Volunteers
NCT03058965Phase 1Completed
- Sponsor
- Molecular NeuroImaging
- Start
- Nov 2016
- Primary completion
- May 2018
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Molecular NeuroImaging. Primary endpoint: Tracer uptake (SUV) at 1 year. Started Nov 2016; status: completed.
Beyond the preview
Go deeper on NCT03058965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03058965.